Last reviewed · How we verify
combined oral contaraceptive pills
combined oral contaraceptive pills is a Small molecule drug developed by Cairo University. It is currently FDA-approved. Also known as: Gynera.
At a glance
| Generic name | combined oral contaraceptive pills |
|---|---|
| Also known as | Gynera |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- combined oral contaraceptive pills CI brief — competitive landscape report
- combined oral contaraceptive pills updates RSS · CI watch RSS
- Cairo University portfolio CI
Frequently asked questions about combined oral contaraceptive pills
What is combined oral contaraceptive pills?
combined oral contaraceptive pills is a Small molecule drug developed by Cairo University.
Who makes combined oral contaraceptive pills?
combined oral contaraceptive pills is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).
Is combined oral contaraceptive pills also known as anything else?
combined oral contaraceptive pills is also known as Gynera.
What development phase is combined oral contaraceptive pills in?
combined oral contaraceptive pills is FDA-approved (marketed).
Related
- Manufacturer: Cairo University — full pipeline
- Also known as: Gynera
- Compare: combined oral contaraceptive pills vs similar drugs
- Pricing: combined oral contaraceptive pills cost, discount & access